Risks associated with transfusion of cellular blood components in Canada

S Kleinman, P Chan, P Robillard - Transfusion medicine reviews, 2003 - Elsevier
We provide a comprehensive review of risks associated with allogeneic red blood cell and
platelet transfusions in Canada. The review focuses on clinically symptomatic noninfectious …

Buffy‐coat‐derived pooled platelet concentrates and apheresis platelet concentrates: which product type should be preferred?

H Schrezenmeier, E Seifried - Vox sanguinis, 2010 - Wiley Online Library
There is an ongoing debate whether platelet concentrates (PCs) prepared from either whole‐
blood donations or by plateletpheresis are superior. Usage of these two product types varies …

Prophylactic platelet transfusion for prevention of bleeding in patients with haematological disorders after chemotherapy and stem cell transplantation

L Estcourt, S Stanworth, C Doree… - Cochrane Database …, 2012 - cochranelibrary.com
Background Platelet transfusions are used in modern clinical practice to prevent and treat
bleeding in thrombocytopenic patients with bone marrow failure. Although considerable …

Acetaminophen and diphenhydramine premedication for allergic and febrile nonhemolytic transfusion reactions: good prophylaxis or bad practice?

TL Geiger, SC Howard - Transfusion medicine reviews, 2007 - Elsevier
Febrile nonhemolytic and allergic reactions are the most common transfusion reactions, but
usually do not cause significant morbidity. In an attempt to prevent these reactions, US …

Guidance on platelet transfusion for patients with hypoproliferative thrombocytopenia

S Nahirniak, SJ Slichter, S Tanael, P Rebulla… - Transfusion medicine …, 2015 - Elsevier
Patients with hypoproliferative thrombocytopenia are at an increased risk for hemorrhage
and alloimmunization to platelets. Updated guidance for optimizing platelet transfusion …

A critical comparison of platelet preparation methods

RR Vassallo, S Murphy - Current opinion in hematology, 2006 - journals.lww.com
We present a literature-based review of the relative merits of apheresis-derived and whole-
blood-derived platelets. Additional studies are needed in order to define the optimal …

Comparison of different platelet count thresholds to guide administration of prophylactic platelet transfusion for preventing bleeding in people with haematological …

LJ Estcourt, SJ Stanworth, C Doree… - Cochrane Database …, 2015 - cochranelibrary.com
Background Platelet transfusions are used in modern clinical practice to prevent and treat
bleeding in people who are thrombocytopenic due to bone marrow failure. Although …

Platelet transfusion therapy

SJ Slichter - Hematology/oncology clinics of North America, 2007 - Elsevier
This article provides guidelines for the appropriate use of platelet transfusions to reduce
unnecessary transfusions, thereby avoiding transfusion-related risks to the patients and the …

A therapeutic‐only versus prophylactic platelet transfusion strategy for preventing bleeding in patients with haematological disorders after myelosuppressive …

GL Crighton, LJ Estcourt, EM Wood… - Cochrane Database …, 2015 - cochranelibrary.com
Background Platelet transfusions are used in modern clinical practice to prevent and treat
bleeding in thrombocytopenic patients with bone marrow failure. Although considerable …

Comparing the efficacy and safety of apheresis and whole blood–derived platelet transfusions: a systematic review

NM Heddle, DM Arnold, D Boye, KE Webert… - …, 2008 - Wiley Online Library
BACKGROUND: A systematic review and meta‐analysis was performed to determine if there
were differences between apheresis platelet concentrates (APCs) or platelets (PLTs) …